Description
A prodrug form of tebipenem; metabolized by CES in intestinal epithelial cells to form tebipenem; active against methicillin-sensitive and -resistant S. aureus (MIC90s = ≤0.125 and 16 µg/ml, respectively), as well as E. faecalis, E. coli., K. pneumoniae, E. aerogenes, H. influenzae, and P. aeruginosa (MIC90s = 32, 1, 0.5, ≤0.125, 0.25, and 64 µg/ml, respectively); increases survival in mouse models of sepsis induced by S. aureus, E. coli, or P. aeruginosa at 50 and 100 mg/kg
Formal name: (4R,5S,6S)-3-[[1-(4,5-dihydro-2-thiazolyl)-3-azetidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, (2,2-dimethyl-1-oxopropoxy)methyl ester
Synonyms: TBPM-PI
Molecular weight: 497.6
CAS: 161715-24-8
Purity: ≥98%
Formulation: A crystalline solid